| Filgrastim studied in …STUDIED_INderived200 of 767show all (up to 200) |
|---|
| → studied in | NCT06738368Phase 2 · suspended Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia · 767 trials list this drug (48 active) | — | — | T Acute Lymphoblastic Leukemia,B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07775313Phase 1/Phase 2 · enrolling by invitation Base-Edited Hematopoietic Stem/Progenitor Cell Gene Therapy for Treatment of CXCR4-WHIM · 767 trials list this drug (48 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00092222Phase 2 · active not recruiting Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity · 767 trials list this drug (48 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04684368Phase 2 · recruiting A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT · 767 trials list this drug (48 active) | — | — | Mixed Germ Cell Tumor,Central Nervous System Nongerminomatous Germ Cell Tumor,Choriocarcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07012044Phase 1 · recruiting A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia · 767 trials list this drug (48 active) | — | — | Acute Myeloid Leukemia,Acute Myeloid Leukemia Post Cytotoxic Therapy | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00801489Phase 2 · recruiting Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome · 767 trials list this drug (48 active) | — | — | De Novo Myelodysplastic Syndrome,Myelodysplastic Syndrome with Excess Blasts,Adult Acute Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03214562Phase 1/Phase 2 · recruiting Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia · 767 trials list this drug (48 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04375631Phase 1 · recruiting CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia · 767 trials list this drug (48 active) | — | — | Myelodysplastic Syndrome,Acute Leukemia of Ambiguous Lineage,Acute Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05535166Phase 2 · recruiting Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma · 767 trials list this drug (48 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01318317Phase 1/Phase 2 · active not recruiting Genetically Engineered Lymphocyte Therapy After Peripheral Blood Stem Cell Transplant in Treating Patients With High-Risk, Intermediate-Grade, B-cell Non-Hodgkin Lymphoma · 767 trials list this drug (48 active) | — | — | Non-Hodgkin Lymphoma,Grade 3 Follicular Lymphoma,Mantle Cell Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05436418Phase 1/Phase 2 · recruiting The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation · 767 trials list this drug (48 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04759586Phase 3 · active not recruiting Nivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma · 767 trials list this drug (48 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05052957Phase 2 · recruiting hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM) · 767 trials list this drug (48 active) | — | — | Glioblastoma,Adult Glioblastoma,Supratentorial Glioblastoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02582697Phase 3 · recruiting Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours · 767 trials list this drug (48 active) | — | — | Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07257419Phase 1 · recruiting CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma · 767 trials list this drug (48 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Childhood Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00334815Phase 2 · active not recruiting Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery · 767 trials list this drug (48 active) | — | — | Lung Large Cell Carcinoma,Lung Squamous Cell Carcinoma,Lung Adenocarcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00792948Phase 2 · active not recruiting Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia · 767 trials list this drug (48 active) | — | — | Acute Lymphoblastic Leukemia,Adult Acute Lymphoblastic Leukemia,Adult B Acute Lymphoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05722015Phase 3 · active not recruiting A Study of Subcutaneous (SC) Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77) · 767 trials list this drug (48 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06212752Phase 3 · active not recruiting A Study of Subcutaneous (SC) Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77)-Japan Extension · 767 trials list this drug (48 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05796570Phase 2 · active not recruiting A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combined With Filgrastim for Children and Young Adults With AML, MDS and Related Myeloid Malignancies · 767 trials list this drug (48 active) | — | — | Myeloid Neoplasm,Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03007147Phase 3 · active not recruiting Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia · 767 trials list this drug (48 active) | — | — | Acute Lymphoblastic Leukemia,B Acute Lymphoblastic Leukemia,T Acute Lymphoblastic Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03147612Phase 2 · active not recruiting Low-Intensity Chemotherapy, Ponatinib and Blinatumomab in Treating Patients With Philadelphia Chromosome-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia · 767 trials list this drug (48 active) | — | — | Acute Lymphoblastic Leukemia,Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive,Blast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07604233Phase 1/Phase 2 · not yet recruiting Phase 1/2 FLAG-IDA, VEN and Asciminib in CML and Ph+ AML · 767 trials list this drug (48 active) | — | — | Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07224100Phase 2 · recruiting Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma · 767 trials list this drug (48 active) | — | — | Lymphoblastic Lymphoma,B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1,B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07759102Phase 1 · not yet recruiting Allogeneic ORCA-Q Stem Cell Transplant for the Treatment of Relapsed and Refractory High Risk Multiple Myeloma · 767 trials list this drug (48 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03220022Phase 1 · active not recruiting Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell Lymphomas · 767 trials list this drug (48 active) | — | — | AIDS-Related Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03907488Phase 3 · active not recruiting Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma · 767 trials list this drug (48 active) | — | — | Classic Hodgkin Lymphoma,Lymphocyte-Rich Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006436Phase 2 · completed EPOCH and Rituximab to Treat Non-Hodgkin's Lymphoma in Patients With HIV Infection · 767 trials list this drug (48 active) | — | — | Lymphoma,AIDS-Related Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07064018Phase 1/Phase 2 · recruiting Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies · 767 trials list this drug (48 active) | — | — | Soft Tissue Sarcoma,Lung Non-Small Cell Carcinoma,Malignant Ovarian Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04022239Phase 1/Phase 2 · recruiting Bendamustine With or Without Cyclophosphamide in Preventing GVHD in Patients Undergoing Stem Cell Transplant · 767 trials list this drug (48 active) | — | — | Hematopoietic and Lymphatic System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06942039early Phase 1 · recruiting Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation · 767 trials list this drug (48 active) | — | — | Central Nervous System Embryonal Tumor,Atypical Teratoid/Rhabdoid Tumor,Central Nervous System Embryonal Tumor with Rhabdoid Features+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01783535Phase 2 · active not recruiting Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma · 767 trials list this drug (48 active) | — | — | Retinoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01012297Phase 3 · terminated Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma · 767 trials list this drug (48 active) | — | — | Uterine Corpus Sarcoma,Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03755804Phase 2 · active not recruiting Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17 · 767 trials list this drug (48 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07647068Phase 2 · not yet recruiting Autologous Tumor Infiltrating Lymphocytes With Interleukin-2 for the Treatment of Locally Advanced, Recurrent or Metastatic Gastrointestinal Stromal Tumors · 767 trials list this drug (48 active) | — | — | Gastrointestinal Stromal Tumor,Malignant Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04959175Phase 1/Phase 2 · recruiting Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies · 767 trials list this drug (48 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03247088Phase 1/Phase 2 · active not recruiting Sorafenib, Busulfan and Fludarabine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia Undergoing Donor Stem Cell Transplant · 767 trials list this drug (48 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00392327Phase 3 · completed Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET · 767 trials list this drug (48 active) | — | — | Medulloblastoma,Anaplastic Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07278856Phase 1 · recruiting Ruxolitinib in Combination With CHOP Chemotherapy for the Treatment of Untreated Nodal T-Follicular Helper Cell Lymphomas · 767 trials list this drug (48 active) | — | — | Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma,Follicular Helper T-Cell Lymphoma,Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07052370Phase 1 · recruiting TCRαβ-depleted Progenitor Cell Graft With Early Memory T-cell DLI, Plus Selected Use of Blinatumomab, in naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies · 767 trials list this drug (48 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04250051Phase 1 · terminated Ivosidenib and Combination Chemotherapy for the Treatment of IDH1 Mutant Relapsed or Refractory Acute Myeloid Leukemia · 767 trials list this drug (48 active) | — | — | Myelodysplastic Syndrome,Myeloproliferative Neoplasm,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04195633Phase 2 · recruiting Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies · 767 trials list this drug (48 active) | — | — | Acute Leukemia,Acute Lymphoblastic Leukemia,Anaplastic Large Cell Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03434730Phase 2 · completed Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation · 767 trials list this drug (48 active) | — | — | Leukemia,Acute Leukemia,Acute Lymphoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00077285Phase 2 · active not recruiting Irinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk Rhabdomyosarcoma · 767 trials list this drug (48 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06928662Phase 1/Phase 2 · recruiting Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse · 767 trials list this drug (48 active) | — | — | Myelodysplastic Syndrome,Secondary Acute Myeloid Leukemia,Acute Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06926751Phase 2 · recruiting Telpegfilgrastim vs Filgrastim for Secondary Prevention of Chemotherapy-Induced Neutropenia in Pediatric Solid Tumors · 767 trials list this drug (48 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01920932Phase 2 · active not recruiting Adcetris (Brentuximab Vedotin), Combination Chemotherapy, and Radiation Therapy in Treating Younger Patients With Stage IIB, IIIB and IV Hodgkin Lymphoma · 767 trials list this drug (48 active) | — | — | Childhood Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01096368Phase 3 · completed Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma · 767 trials list this drug (48 active) | — | — | Anaplastic Ependymoma,Ependymoma,Brain Ependymoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00253435Phase 2 · completed N2001-02: I-MIBG With Intensive Chemotherapy and Autologous Stem Cell Rescue for High-Risk Neuroblastoma · 767 trials list this drug (48 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04898894Phase 1 · active not recruiting Study of Selinexor and Venetoclax in Combination With Chemotherapy in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia · 767 trials list this drug (48 active) | — | — | Acute Leukemia of Ambiguous Lineage,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03856216Phase 2 · terminated Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Leukemia or Lymphoma Undergoing Stem Cell Transplantation · 767 trials list this drug (48 active) | — | — | Lymphocytic Neoplasm,Lymphoma,Acute Lymphoblastic Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00083135Phase 1 · completed N2000-01: Double Infusion of Iodine I 131 Metaiodobenzylguanidine Followed by Autologous Stem Cell Transplantation · 767 trials list this drug (48 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05170828Phase 1 · withdrawn Cryopreserved MMUD BM With PTCy for Hematologic Malignancies · 767 trials list this drug (48 active) | — | — | Acute Leukemia,Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003042Phase 2 · completed Chemotherapy and Stem Cell Transplantation in Treating Patients With Stage IIIB Breast Cancer · 767 trials list this drug (48 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06709495Phase 1/Phase 2 · recruiting Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas · 767 trials list this drug (48 active) | — | — | Sarcoma,Ewing Sarcoma,Osteosarcoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03467386Phase 1 · suspended Total Marrow and Lymphoid Irradiation Before Donor Transplant and Cyclophosphamide in Treating Patients With Acute Myeloid Leukemia · 767 trials list this drug (48 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03301350Phase 2 · completed Neoadjuvant Carbo/Paclitaxel Followed by Doxorubicin/Cyclophosphamide in Breast Cancer · 767 trials list this drug (48 active) | — | — | Malignant Breast Neoplasm,Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05799612Phase 1 · withdrawn Phase I Study of TH1 Dendritic Cell Immunotherapy for the Treatment of Cutaneous Angiosarcoma · 767 trials list this drug (48 active) | — | — | Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00336024Phase 3 · completed Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma · 767 trials list this drug (48 active) | — | — | Medulloblastoma,Anaplastic Medulloblastoma,Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05317403Phase 1 · recruiting Venetoclax to Augment Epigenetic Modification and Chemotherapy · 767 trials list this drug (48 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05115630Phase 2 · completed Off-the-shelf NK Cells + SCT for Myeloid Malignancies · 767 trials list this drug (48 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia,Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03317899Phase 2 · completed Stem Cell Transplant With or Without Tbo-filgrastim in Treating Patients With Multiple Myeloma or Non-Hodgkin Lymphoma · 767 trials list this drug (48 active) | — | — | Multiple Myeloma,Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00534469Phase 2 · completed Auto BMT for Non-M3 AML in 1st Remission in Pts </=60y of Age Using Busulfan/FTBI & VP16 as a Prep R · 767 trials list this drug (48 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02337985Phase 1 · active not recruiting Gene Therapy and Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma · 767 trials list this drug (48 active) | — | — | AIDS-Related Burkitt Lymphoma,AIDS-Related Non-Hodgkin Lymphoma,AIDS-Related Diffuse Large B-cell Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03263936Phase 1 · completed Epigenetic Reprogramming in Relapse/Refractory AML · 767 trials list this drug (48 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00911183Phase 2 · completed Diffuse Large B Cell Non-Hodgkin's Lymphoma in the Vulnerable/Frail Elderly. A Multicentric Randomized Phase II Trial · 767 trials list this drug (48 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00278408Phase 3 · completed Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma · 767 trials list this drug (48 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00357565Phase 2 · completed Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia · 767 trials list this drug (48 active) | — | — | Leukemia,Childhood Myelodysplastic Syndrome,Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05032183Phase 1/Phase 2 · terminated Tagraxofusp and Low-Intensity Chemotherapy for the Treatment of CD123 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma · 767 trials list this drug (48 active) | — | — | Lymphoblastic Lymphoma,Adult Lymphoblastic Lymphoma,B Acute Lymphoblastic Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00049595Phase 3 · completed Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma · 767 trials list this drug (48 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00112827Phase 1/Phase 2 · completed Melphalan and Radiation Therapy Followed By Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Stage I, Stage II, or Stage III Multiple Myeloma · 767 trials list this drug (48 active) | — | — | Multiple Myeloma,Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02331134NA · completed Tissue and Hematopoietic/Mesenchymal Stem Cell for Humanized Xenograft Studies in Melanoma and Squamous Head and Neck Cancer · 767 trials list this drug (48 active) | — | — | Malignant Head and Neck Neoplasm,Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04752163Phase 1/Phase 2 · terminated DS-1594b With or Without Azacitidine, Venetoclax, or Mini-HCVD for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia · 767 trials list this drug (48 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03944915Phase 2 · completed De-Escalation Therapy for Human Papillomavirus Negative Disease · 767 trials list this drug (48 active) | — | — | Squamous Cell Carcinoma,Head and Neck Squamous Cell Carcinoma,Human Papillomavirus-Related Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03417284Phase 1/Phase 2 · completed Melphalan Hydrochloride in Treating Participants With Newly-Diagnosed Multiple Myeloma Undergoing Donor Stem Cell Transplantation · 767 trials list this drug (48 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04781959Phase 4 · completed A Randomized, Multicenter Pragmatic Trial Comparing Bone Pain From a Single Dose of Pegfilgrastim to 5 Doses of Daily Filgrastim in Breast Cancer Patients Receiving Neoadjuvant/Adjuvant Chemotherapy · 767 trials list this drug (48 active) | — | — | Early Stage Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00638898Phase 1 · completed Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor · 767 trials list this drug (48 active) | — | — | Solid Neoplasm,Adult Solid Neoplasm,Childhood Solid Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04023669Phase 1 · completed Evaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcitabine for Children and Adolescents With Refractory or Recurrent Group 3/Group 4 or SHH Medulloblastoma Brain Tumors · 767 trials list this drug (48 active) | — | — | Central Nervous System Neoplasm,Malignant Central Nervous System Neoplasm,Medulloblastoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02880293NA · completed Haploidentical (Half-matched) Related Donor Stem Cell Transplantation Using Killer Immunoglobulin-like Receptors in Addition to Normal Selection Factors to Determine the Best Donor · 767 trials list this drug (48 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02043847Phase 1 · completed TMI With HD Mel in ASCT for R/R Multiple Myeloma (BMT-03) · 767 trials list this drug (48 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02177695Phase 2 · completed S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer · 767 trials list this drug (48 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06221683Phase 2 · recruiting Clinical Study of Induction Therapy Options Based on Molecular Subtyping and MRD in Children and Adolescents With AML · 767 trials list this drug (48 active) | — | — | Acute Myeloid Leukemia,Childhood Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06504901not yet recruiting Evaluation of Efficacy and Safety of PD-1 Monoclonal Antibody in Combination With rhG-CSF, IL-2, and CapeOX in Initially Resectable Synchronous Colorectal Liver Metastases · 767 trials list this drug (48 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00557193Phase 3 · completed Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia · 767 trials list this drug (48 active) | — | — | Acute Lymphoblastic Leukemia,Childhood T Acute Lymphoblastic Leukemia,Acute Undifferentiated Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01798004Phase 1 · completed Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma · 767 trials list this drug (48 active) | — | — | Ganglioneuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00547196NA · completed AlloHCT From Matched Unrelated Donors in Pts w/ Advanced Hematologic Malignancies & Disorders · 767 trials list this drug (48 active) | — | — | Leukemia,Lymphoma,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03434262Phase 1 · completed SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors · 767 trials list this drug (48 active) | — | — | Neoplasm,Embryonal Neoplasm,Central Nervous System Embryonal Tumor+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03188172Phase 2 · unknown MUK Nine b: OPTIMUM Treatment Protocol · 767 trials list this drug (48 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00678327Phase 3 · completed Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma · 767 trials list this drug (48 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00653068Phase 3 · completed Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System · 767 trials list this drug (48 active) | — | — | Childhood Atypical Teratoid/Rhabdoid Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00110110Phase 2 · unknown Combination Chemotherapy and Cyclosporine Followed by Focal Therapy for Bilateral Retinoblastoma · 767 trials list this drug (48 active) | — | — | Retinoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00381680Phase 3 · completed Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia · 767 trials list this drug (48 active) | — | — | Childhood B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00020371Phase 1 · completed BMS-247550 in Treating Patients With Cancers That Have Not Responded to Previous Therapy · 767 trials list this drug (48 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00304070Phase 3 · completed Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor · 767 trials list this drug (48 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00085202Phase 3 · completed Treatment of Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor · 767 trials list this drug (48 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06188676Phase 3 · recruiting Multicenter Study of Safety and Efficacy Nivolumab at the Fixed Dose 40 mg (Nivo40) in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed PMBL · 767 trials list this drug (48 active) | — | — | Mediastinal Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004192Phase 2 · completed Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin's Lymphoma · 767 trials list this drug (48 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06116734Phase 3 · unknown Lapelga vs Gastrofil · 767 trials list this drug (48 active) | — | — | Lymphoma,Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02728531Phase 1 · completed Bendamustine and Rituximab Alternating With Cytarabine and Rituximab for Untreated Mantle Cell Lymphoma · 767 trials list this drug (48 active) | — | — | Mantle Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03240861Phase 1 · terminated Genetically Engineered PBMC and PBSC Expressing NY-ESO-1 TCR After a Myeloablative Conditioning Regimen to Treat Patients With Advanced Cancer · 767 trials list this drug (48 active) | — | — | Malignant Neoplasm,Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03197935Phase 3 · completed A Study to Investigate Atezolizumab and Chemotherapy Compared With Placebo and Chemotherapy in the Neoadjuvant Setting in Participants With Early Stage Triple Negative Breast Cancer · 767 trials list this drug (48 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03096782Phase 2 · completed Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma · 767 trials list this drug (48 active) | — | — | Acute Leukemia,Acute Lymphoblastic Leukemia,Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01177683Phase 1/Phase 2 · terminated Bendamustine in Combination With Bortezomib and Pegylated Liposomal Doxorubicin for Multiple Myeloma · 767 trials list this drug (48 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00562640Phase 1 · completed Autologous T Cells With or Without Cyclophosphamide and Fludarabine in Treating Patients With Recurrent or Persistent Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer (Fludarabine Treatment Closed as of 12/01/2009) · 767 trials list this drug (48 active) | — | — | Malignant Fallopian Tube Neoplasm,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00665457Phase 2 · terminated Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery · 767 trials list this drug (48 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02642965Phase 1/Phase 2 · completed Liposome-encapsulated Daunorubicin-Cytarabine, Fludarabine Phosphate, Cytarabine, and Filgrastim in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia · 767 trials list this drug (48 active) | — | — | Secondary Acute Myeloid Leukemia,Acute Myeloid Leukemia Post Cytotoxic Therapy,Childhood Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00039130Phase 2 · completed Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia · 767 trials list this drug (48 active) | — | — | Leukemia,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02774291early Phase 1 · terminated Anti-NY ESO-1 mTCR Peripheral Blood Lymphocytes · 767 trials list this drug (48 active) | — | — | Malignant Neoplasm,Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006734Phase 3 · completed Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor · 767 trials list this drug (48 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00074165Phase 2 · terminated Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen · 767 trials list this drug (48 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003927Phase 1 · completed Combination Chemotherapy, Amifostine, and Peripheral Stem Cell Transplantation in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer · 767 trials list this drug (48 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00046930Phase 3 · completed Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia · 767 trials list this drug (48 active) | — | — | Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02728050Phase 1/Phase 2 · completed Filgrastim, Cladribine, Cytarabine, and Mitoxantrone With Sorafenib in Treating Patients With Newly-Diagnosed, Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome · 767 trials list this drug (48 active) | — | — | Myelodysplastic Syndrome,Myeloproliferative Neoplasm,Acute Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00274924Phase 2 · completed Rituximab and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Non-Hodgkin's Lymphoma · 767 trials list this drug (48 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002868Phase 3 · completed Interferon-alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia · 767 trials list this drug (48 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003027Phase 3 · completed Combination Chemotherapy With or Without Interleukin-2 and Interferon Alfa in Treating Patients With Metastatic Melanoma · 767 trials list this drug (48 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003309Phase 2 · completed Combination Chemotherapy Plus Radiation Therapy in Treating Adult Patients With Brain Cancer · 767 trials list this drug (48 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003353Phase 2 · completed High-Dose Melphalan Plus Peripheral Stem Cell Transplantation in Treating Patients With Primary Systemic Amyloidosis · 767 trials list this drug (48 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003388Phase 2 · completed Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma · 767 trials list this drug (48 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006390Phase 2 · completed Alemtuzumab Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia · 767 trials list this drug (48 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00052884Phase 1 · terminated Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Peripheral Stem Cell Transplantation · 767 trials list this drug (48 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00049348Phase 2 · completed Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer · 767 trials list this drug (48 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00074269Phase 2 · terminated Allogeneic Stem Cell Transplant After ATG, High-Dose Melphalan, and Fludarabine for Patients With Breast Cancer · 767 trials list this drug (48 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05330377Phase 1 · withdrawn GM-CLAG in Relapsed/Refractory FLT3-mutated AML · 767 trials list this drug (48 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01019850Phase 1 · completed N2007-03: Vorinostat and 131-I MIBG in Treating Patients With Resistant or Relapsed Neuroblastoma · 767 trials list this drug (48 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01256398Phase 2 · completed Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia · 767 trials list this drug (48 active) | — | — | Acute Lymphoblastic Leukemia,Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01899326NA · terminated Desipramine Hydrochloride and Filgrastim For Stem Cell Mobilization in Patients With Multiple Myeloma Undergoing Stem Cell Transplant · 767 trials list this drug (48 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02960646Phase 1 · completed Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies · 767 trials list this drug (48 active) | — | — | Acute Lymphoblastic Leukemia,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03019640Phase 2 · completed Umbilical Cord Blood NK Cells, Rituximab, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma · 767 trials list this drug (48 active) | — | — | Diffuse Large B-Cell Lymphoma,Follicular Lymphoma,Indolent Adult Non-Hodgkin Lymphoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01746173Phase 2 · terminated CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma · 767 trials list this drug (48 active) | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01028716Phase 2 · terminated Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies · 767 trials list this drug (48 active) | — | — | Acute Leukemia,Acute Lymphoblastic Leukemia,Anaplastic Large Cell Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02593123Phase 2 · completed Adoptive Immunotherapy in Relapsed Hematological Malignancy: Early GVHD Prophylaxis · 767 trials list this drug (48 active) | — | — | Leukemia,Lymphoma,Acute Lymphoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00096460Phase 2/Phase 3 · terminated Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202) · 767 trials list this drug (48 active) | — | — | Follicular Lymphoma,Grade 3 Follicular Lymphoma,Grade 1 Follicular Lymphoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00423514Phase 1/Phase 2 · completed Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other Disease · 767 trials list this drug (48 active) | — | — | Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03518112Phase 2 · terminated Low-Intensity Chemotherapy and Blinatumomab in Treating Patients With Philadelphia Chromosome Negative Relapsed or Refractory Acute Lymphoblastic Leukemia · 767 trials list this drug (48 active) | — | — | B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02943733Phase 1 · terminated Safety of TAS-102 in Combination With Temozolomide for Metastatic Pancreatic NETs · 767 trials list this drug (48 active) | — | — | Neoplasm,Malignant Neoplasm,Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02494921Phase 1/Phase 2 · completed LEE011 (Ribociclib) in Combination With Docetaxel Plus Prednisone in mCRPC · 767 trials list this drug (48 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00822120Phase 2 · completed S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma · 767 trials list this drug (48 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00669669Phase 1/Phase 2 · terminated O6-Benzylguanine-Mediated Tumor Sensitization With Chemoprotected Autologous Stem Cell in Treating Patients With Malignant Gliomas · 767 trials list this drug (48 active) | — | — | Glioblastoma,Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00432094Phase 2 · completed Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors · 767 trials list this drug (48 active) | — | — | Childhood Germ Cell Tumor,Teratoma,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00061945Phase 1/Phase 2 · completed Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia · 767 trials list this drug (48 active) | — | — | Adult Acute Lymphoblastic Leukemia,Childhood Acute Lymphoblastic Leukemia,Childhood B Acute Lymphoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00450450Phase 3 · completed Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other Diseases · 767 trials list this drug (48 active) | — | — | Juvenile Myelomonocytic Leukemia,Myelodysplastic Syndrome,Childhood Acute Lymphoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00567567Phase 3 · completed Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma · 767 trials list this drug (48 active) | — | — | Neuroblastoma,Regional Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01026220Phase 3 · completed Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma · 767 trials list this drug (48 active) | — | — | Childhood Hodgkin Lymphoma,Childhood Nodular Lymphocyte Predominant B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00001563Phase 2 · completed EPOCH Chemotherapy +/- IL-12 for Previously Untreated and EPOCH Plus Rituximab for Previously Treated Patients With AIDS-Associated Lymphoma · 767 trials list this drug (48 active) | — | — | Non-Hodgkin Lymphoma,AIDS-Related Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02190721Phase 2 · completed A Study to Evaluate 5 μg/kg Tbo-filgrastim in Infants, Children and Adolescents With Solid Tumors Without Bone Marrow Involvement · 767 trials list this drug (48 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00118209Phase 3 · completed Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma · 767 trials list this drug (48 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02756572Phase 2 · completed Early Allogeneic Hematopoietic Cell Transplantation in Treating Patients With Relapsed or Refractory High-Grade Myeloid Neoplasms · 767 trials list this drug (48 active) | — | — | Myeloid Neoplasm,High Grade Malignant Neoplasm,Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00000626Phase 2 · completed Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease · 767 trials list this drug (48 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00063999Phase 3 · completed Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer · 767 trials list this drug (48 active) | — | — | Malignant Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01366183unknown Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer · 767 trials list this drug (48 active) | — | — | Malignant Fallopian Tube Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01946152Phase 1/Phase 2 · terminated Pomalidomide, Dexamethasone, and Filgrastim-sndz in Treating Patients With Relapsed or Refractory Multiple Myeloma · 767 trials list this drug (48 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00499616Phase 3 · completed Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma · 767 trials list this drug (48 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00185640Phase 2 · completed Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) for Older Patients With Hematologic Malignancies · 767 trials list this drug (48 active) | — | — | Liquid Tumor,Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01787474Phase 1 · completed Donor Natural Killer Cells in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · 767 trials list this drug (48 active) | — | — | Acute Myeloid Leukemia,Adult Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00562978Phase 1/Phase 2 · completed Yttrium Y 90 Ibritumomab Tiuxetan, Etoposide, Cyclophosphamide, and an AHSCT in Non-Hodgkin's Lymphoma Patients · 767 trials list this drug (48 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00052936Phase 3 · completed Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma · 767 trials list this drug (48 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00053768Phase 3 · completed Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma · 767 trials list this drug (48 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03892421Phase 1/Phase 2 · completed Outpatient Administration of R-DHAP in Relapsed/Refractory Non-Hodgkin Lymphoma · 767 trials list this drug (48 active) | — | — | Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02037256NA · completed Bortezomib and Filgrastim to Promote Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma · 767 trials list this drug (48 active) | — | — | Hairy Cell Leukemia,Multiple Myeloma,Non-Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01685411NA · terminated Busulfan and Cyclophosphamide Followed By ALLO BMT · 767 trials list this drug (48 active) | — | — | Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01045460Phase 2 · completed Trial of Activated Marrow Infiltrating Lymphocytes Alone or in Conjunction With an Allogeneic Granulocyte Macrophage Colony-stimulating Factor (GM-CSF)-Based Myeloma Cellular Vaccine in the Autologous Transplant Setting in Multiple Myeloma · 767 trials list this drug (48 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00302003Phase 3 · completed Combination Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Lymphoma · 767 trials list this drug (48 active) | — | — | Hodgkin Lymphoma,Childhood Hodgkin Lymphoma,Childhood Favorable Prognosis Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00381940Phase 2 · completed Bortezomib, Ifosfamide, and Vinorelbine Tartrate in Treating Young Patients With Hodgkin's Lymphoma That is Recurrent or Did Not Respond to Previous Therapy · 767 trials list this drug (48 active) | — | — | Adult Hodgkin Lymphoma,Adult Nodular Lymphocyte Predominant B-Cell Lymphoma,Childhood Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002611Phase 3 · completed Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney Cancer · 767 trials list this drug (48 active) | — | — | Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003860Phase 2 · completed Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Small Cell Lung Cancer · 767 trials list this drug (48 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02078102Phase 2 · completed A Phase II Trial Using Meloxicam Plus Filgrastim in Patients With Multiple Myeloma and Non-Hodgkin's Lymphoma · 767 trials list this drug (48 active) | — | — | Multiple Myeloma,Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02392793Phase 1 · completed Talazoparib Plus Irinotecan With or Without Temozolomide in Children With Refractory or Recurrent Solid Malignancies · 767 trials list this drug (48 active) | — | — | Childhood Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00469014Phase 2 · completed Busulfan, Fludarabine, Clofarabine With Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia · 767 trials list this drug (48 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia,Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00058422Phase 2 · completed Rituximab and Combination Chemotherapy Combined With Yttrium Y 90 Ibritumomab Tiuxetan in Treating Older Patients With Previously Untreated B-Cell Lymphoma · 767 trials list this drug (48 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01987596Phase 3 · terminated Study of Fixed vs. Flexible Filgrastim to Accelerate Bone Marrow Recovery After Chemotherapy in Children With Cancer · 767 trials list this drug (48 active) | — | — | Childhood Solid Neoplasm,Choroid Plexus Neoplasm,Osteosarcoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00101010Phase 2 · completed Rituximab and Combination Chemotherapy in Treating Older Patients With Diffuse Large B-Cell Lymphoma · 767 trials list this drug (48 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00822770Phase 1/Phase 2 · completed Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) With Busulfan, Fludarabine and Thymoglobulin · 767 trials list this drug (48 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00014222Phase 3 · completed Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer · 767 trials list this drug (48 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00981799Phase 1/Phase 2 · terminated Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL · 767 trials list this drug (48 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00075621Phase 2 · completed Tandem Autologous Stem Cell Transplantation in Treating Patients With Primary Systemic (AL) Amyloidosis · 767 trials list this drug (48 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00309842Phase 2 · completed Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases · 767 trials list this drug (48 active) | — | — | Leukemia,Lymphoma,Acute Lymphoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004114Phase 1 · withdrawn Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Hematologic Cancer · 767 trials list this drug (48 active) | — | — | Leukemia,Lymphoma,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02685111Phase 2 · terminated Intermittent G-CSF in Patients With Breast Cancer Receiving Adjuvant Docetaxel, Doxorubicin, and Cyclophosphamide (TAC) · 767 trials list this drug (48 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00054236Phase 1 · completed Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia · 767 trials list this drug (48 active) | — | — | Leukemia,Lymphoma,Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03506802Phase 1 · withdrawn TCR Genetically Engineered PBMC and PBSC After Melphalan Conditioning Regimen in Treating Participants With Relapsed and Refractory Multiple Myeloma · 767 trials list this drug (48 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003086Phase 1/Phase 2 · terminated Repeated Bone Marrow Transplantation in Treating Women With Advanced Breast Cancer · 767 trials list this drug (48 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003060Phase 1 · terminated Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Metastatic Melanoma · 767 trials list this drug (48 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02816112Phase 4 · completed Granulocyte-colony Stimulating Factors or Antibiotics for Primary Prophylaxis for Febrile Neutropenia · 767 trials list this drug (48 active) | — | — | Early Stage Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00303719Phase 2 · terminated Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy · 767 trials list this drug (48 active) | — | — | Leukemia,Lymphoma,Multiple Myeloma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01533207Phase 3 · terminated Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery · 767 trials list this drug (48 active) | — | — | Uterine Corpus Sarcoma,Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00720109Phase 2/Phase 3 · completed Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia · 767 trials list this drug (48 active) | — | — | Acute Lymphoblastic Leukemia,Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1,Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002866Phase 1 · completed Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer · 767 trials list this drug (48 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003032Phase 3 · completed High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Metastatic or Recurrent Breast Cancer · 767 trials list this drug (48 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00541125Phase 2 · completed G-CSF in Preventing Neutropenia During First-Line Treatment With Chemotherapy and Bevacizumab in Patients With Metastatic Colorectal Cancer · 767 trials list this drug (48 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02921061Phase 1/Phase 2 · completed Decitabine With GCLAM for Adults With Newly Diagnosed, Relapsed, or Refractory AML or High-Risk MDS · 767 trials list this drug (48 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia,Adult Acute Myeloid Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00245011Phase 2 · completed Samarium Sm 153 and Stem Cell Transplant Followed By Radiation Therapy Patients With Osteosarcoma · 767 trials list this drug (48 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01629511Phase 1/Phase 2 · terminated Allogeneic Stem Cell Transplant for CLL · 767 trials list this drug (48 active) | — | — | Chronic Lymphocytic Leukemia,Prolymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00939653Phase 2 · terminated T2007-002 Clofarabine, Etoposide, Cyclophosphamide in Relapsed Acute Myelogenous Leukemia (AML) · 767 trials list this drug (48 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00007813Phase 1 · completed Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors · 767 trials list this drug (48 active) | — | — | Childhood Germ Cell Tumor,Extragonadal Germ Cell Tumor,Sarcoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00354744Phase 3 · completed High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma · 767 trials list this drug (48 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03579927Phase 1/Phase 2 · withdrawn CAR.CD19-CD28-zeta-2A-iCasp9-IL15-Transduced Cord Blood NK Cells, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Participants With B-cell Lymphoma · 767 trials list this drug (48 active) | — | — | B-Cell Non-Hodgkin Lymphoma,Diffuse Large B-Cell Lymphoma,Follicular Lymphoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00490529Phase 2 · completed Phase 1-2 of a CpG-Activated Whole Cell Vaccine Followed by Autologous Immunotransplant for MCL · 767 trials list this drug (48 active) | — | — | Mantle Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02044796Phase 1/Phase 2 · completed Filgrastim, Cladribine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes · 767 trials list this drug (48 active) | — | — | Myelodysplastic Syndrome,Secondary Acute Myeloid Leukemia,De Novo Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01415765Phase 1/Phase 2 · withdrawn MLN4924 Compared With MLN4924 Plus Chemotherapy for Large B-cell Lymphoma · 767 trials list this drug (48 active) | — | — | Lymphoma,Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |